News & events
Press Releases
December 14, 2021
Immunicom Recruits Dr. Erdal Bozdoğan to Join Leadership Team
December 7, 2021
Immunicom Announces Promising Preliminary Data from its Immunopheresis® Study in Late-Stage Cancer and Metastatic Melanoma Patients Presented at 2021 SITC Congress
November 16, 2021
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe
Get to Know Us
March 23, 2021
Breakthrough Immunotherapy Earns First Regulatory Approval for Triple Negative Breast Cancer (TNBC)
July 9, 2020
Unconventional Weapon in the War on Cancer Revealed
June 10, 2019
Immunicom Announces First Patient Enrollment in Multi-Center, Triple-Negative Breast Cancer Clinical Trial
May 14, 2018
Immunicom’s Immunotherapy Product Receives U.S. FDA Breakthrough Device Designation for the Treatment of Cancer
Get in touch today
Let’s talk about what we can achieve together
Learn more about
our team
our team